Genentech

In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer
Endpoints
Thu, 09/6/18 - 11:42 am
Genentech
Roch
Tecentriq
Avastin
lung cancer
FDA
Pfizer Calls for FDA Guidance to Address False and Misleading Biosimilar Ads
RAPS.org
Tue, 08/28/18 - 08:00 pm
Pfizer
FDA
biosimilars
Amgen
Genentech
drug ads
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Pharmaforum
Tue, 08/28/18 - 10:03 am
Roche
Genentech
Affimed
cancer immunotherapy
drug development
As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California
Fierce Pharma
Wed, 08/15/18 - 10:28 pm
Roche
Genentech
WARN notice
layoffs
California
Genentech, Horizon Earn Spots on List of ‘Companies That Care’
BioSpace
Sat, 07/28/18 - 12:39 pm
Genentech
Horizon Pharma
employees
Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival
Endpoints
Mon, 07/2/18 - 09:37 am
Roche
Tecentriq
Genentech
triple negative breast cancer
Celgene
Abraxane
Microbiome report for week ending 6-24-18
CP Wire
Wed, 06/27/18 - 07:53 pm
Axial Biotherapeutics
Kallyope
Novo Nordisk
CosmosID
microbiome
precisionFDA
Janssen
Microbiotica
Genentech
Microbiome report for week ending 6-24-18
Wed, 06/27/18 - 07:51 pm
Axial Biotherapeutics
Kallyope
Novo Nordisk
CosmosID
microbiome
precisionFDA
Janssen
Microbiotica
Genentech
FDA Approves Genentech’s Rituxan For Rare Autoimmune Disease Pemphigus Vulgaris
CP Wire
Fri, 06/8/18 - 10:07 am
Genentech
Rituxan
FDA
pemphigus vulgaris
Genentech/Roche
Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs
Fierce Biotech
Wed, 06/6/18 - 10:30 am
Genentech
Microbiotica
microbiome
IBD
biomarkers
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Xconomy
Tue, 05/29/18 - 11:36 am
clinical trials
Roche
Genentech
Genmab
JNJ
cancer
Tecentriq
Darzalex
Genentech allies with a metagenomics upstart in New York on a discovery deal jam packed with biobucks
Endpoints
Wed, 05/9/18 - 09:27 pm
Genentech
Roch
New York
Lodo Therapeutics
microbial DNA
FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers
Endpoints
Mon, 05/7/18 - 09:50 am
Roche
Tecentriq
FDA
Genentech
lung cancer
Genentech antibody spotlights new target for antibiotic-resistant bacteria
Fierce Biotech
Sat, 03/24/18 - 09:09 am
Genentech
antibiotic resistance
antibiotics
R&D
drug discovery
BamA enzyme
After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive
Fierce Biotech
Tue, 02/6/18 - 09:51 am
FDA
Bellicum
R&D
Genentech
[forum discussion]Over 50
Cafepharma Message Boards
Tue, 01/23/18 - 04:39 pm
Genentech
Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven
Endpoints
Sat, 01/13/18 - 02:01 pm
Genentech
anti-PD-1 immunotherapy
Forty Seven
Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer
Xconomy
Mon, 11/20/17 - 09:40 am
Roche
lung cancer
Genentech
Tecentriq
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning
Xconomy
Fri, 11/17/17 - 10:19 am
Genentech
FDA
hemophilia A
Hemlibra
Genentech inks $650M deal with protein degradation pioneer Arvinas
Endpoints
Wed, 11/15/17 - 11:10 am
Genentech
targeted protein degradation
Arvinas
R&D

Pages